Evaluation On Provincial Food And Drug Administration Information Transparency

The research starts with the drug regulatory transparency degree. Then make a quantitative analysis of current provincial drug regulatory transparency in our country by constructing the transparency index system. Based on this evaluation system, evaluate the transparency according to the actual website construction situation of all provinces’ drug regulatory agencies. Considering both of the drug reform orientation and the trend of information age, put forward the existing problems and recommendations from the perspective of site-based transparency construction.Glimpsing into the current situation and evaluating the transparency degree, the research would propose a new framework for the evaluation on drug regulatory system transparency, and provide a discussion about practicable strategies in order to promote drug supervision, especially to enhance regulatory transparency degree. Furthermore, provide the theoretical reference and policy recommendations for the policy improvement.Part1 is the introduction. The first part composes of the research background and significance, which includes the international background, the comprehensive domestic background and so on. And analyze the theoretical value and the actual practical value; Then, it outlines the research status from two perspectives of the qualitative and quantitative research, and transparency improvement measures; In the next place, it introduces the research purpose and contents. Next it introduces the object of study, research ideas and methods.Part2 is to introduce the theory and concepts. From three angles, namely, asymmetric information theory, institutional economics and electronic government, analyze the theoretical aspects. And make a transparency index grading assessment form in reference to related document literature.The third part is a fundamental part, in this part, it determines the weight of each index by using Analytic Hierarchy Process(AHP), tests consistency by MATLAB, and builds the drug regulatory transparency evaluation index system mainly from four areas of information disclosure, service, interactive communication and new media application.The fourth part is the main part. It is an empirical study on the provincial Food and Drug Administration websites transparency evaluation in the whole country, mainly from two aspects of general and specific categories by pivot table, statistic description and other methods to analyze the results of the transparency evaluation.The fifth part is the discussion, including six components of the summary, suggestions, safeguard measures, innovation, existing problems, shortcomings problems to be solved and conclusion. In the process of investigation and evaluation around the Food and Drug Administration website transparency, some problems were found, such as website construction issues, the missing construction of core indicators and being hard to find what one wanted. Besides, put forward three recommendations from the macro, meso and micro perspectives, which includes standardization strategy and building transparency in the regulatory system website and construction details, according to the analysis results of the evaluation system.